HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, ...

Please provide your email address to receive an email when new articles are posted on . Pulse Biosciences has announced it received FDA 510(k) clearance for expanding the use of its CellFX System to ...

‌Sebaceous hyperplasia is a harmless, common skin condition that becomes more common with age. It happens when your sebaceous oil glands make too much oil that gets trapped under your skin and causes ...

~ Two oral abstracts highlight positive findings from pivotal studies for the treatment of sebaceous hyperplasia and cutaneous non-genital warts with the CellFX® System ~ ~ Two posters showcase ...

Medically reviewed by Casey Gallagher, MDMedically reviewed by Casey Gallagher, MD Sebaceous hyperplasia is a harmless skin disorder in which the oil gland (sebaceous gland) that surrounds a hair ...

(RTTNews) - Pulse Biosciences, Inc. (PLSE), a bioelectric medicine company, has received FDA clearance for its CellFX System to expand the indication for use in the treatment of sebaceous hyperplasia ...

CASE #2: Sebaceous hyperplasia Sebaceous hyperplasia (SH) is the physical manifestation of enlargement of the sebaceous gland to the point where discrete raised yellow aggregations of cells can be ...

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE) (“Pulse Biosciences” or the “Company”), a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS™) ...

Please provide your email address to receive an email when new articles are posted on . Cutaneous sebaceous carcinomas are less aggressive than their ocular counterparts and may be treated ...